Cargando…

Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysis

BACKGROUND: Amphetamine and methamphetamine use disorders are associated with severe health and social consequences. No pharmacological therapy has been approved for the treatment of these disorders. Psychostimulants can act as maintenance-like therapies for managing substance use among these patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhatt, Meha, Zielinski, Laura, Baker-Beal, Lola, Bhatnagar, Neera, Mouravska, Natalia, Laplante, Phillip, Worster, Andrew, Thabane, Lehana, Samaan, Zainab
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109734/ https://www.ncbi.nlm.nih.gov/pubmed/27842569 http://dx.doi.org/10.1186/s13643-016-0370-x

Ejemplares similares

Adverse outcomes associated with opioid prescription for acute low back pain: a systematic review protocol
por: Mouravska, Natalia, et al.
Publicado: (2017)

Sociodemographic characteristics of patients with children in a methadone maintenance program: a cross-sectional study
por: Luo, Candice, et al.
Publicado: (2019)

The association between cannabis use and suicidal behavior in patients with psychiatric disorders: an analysis of sex differences
por: Naji, Leen, et al.
Publicado: (2018)

Light therapy for non-seasonal depression: systematic review and meta-analysis
por: Perera, Stefan, et al.
Publicado: (2016)

“Don’t Judge a Book by Its Cover”: A Qualitative Study of Methadone Patients’ Experiences of Stigma
por: Woo, Julia, et al.
Publicado: (2017)

Association between cannabis use and treatment outcomes in patients receiving methadone maintenance treatment: a systematic review protocol
por: Zielinski, Laura, et al.
Publicado: (2016)

The Therapeutic Potential of Amphetamine-like Psychostimulants
por: Pires, Bruno, et al.
Publicado: (2023)

Cocaine and amphetamine-like psychostimulants: neurocircuitry and glutamate neuroplasticity
por: Kalivas, Peter W.
Publicado: (2007)

The association between health conditions and cannabis use in patients with opioid use disorder receiving methadone maintenance treatment
por: Shams, Ieta, et al.
Publicado: (2019)

Exploring psychological symptoms and associated factors in patients receiving medication-assisted treatment for opioid-use disorder
por: Rosic, Tea, et al.
Publicado: (2020)

Sensitivity and specificity of self-reported psychiatric diagnoses amongst patients treated for opioid use disorder
por: Leung, Kelly, et al.
Publicado: (2021)

Association between cannabis use and methadone maintenance treatment outcomes: an investigation into sex differences
por: Zielinski, Laura, et al.
Publicado: (2017)

Comparative Untargeted Metabolomics Analysis of the Psychostimulants 3,4-Methylenedioxy-Methamphetamine (MDMA), Amphetamine, and the Novel Psychoactive Substance Mephedrone after Controlled Drug Administration to Humans
por: Steuer, Andrea E., et al.
Publicado: (2020)

Trauma and post-traumatic stress disorder in patients treated for opioid use disorder: findings from a 12-month cohort study
por: Rosic, Tea, et al.
Publicado: (2021)

Epigenetic landscape of amphetamine and methamphetamine addiction in rodents
por: Godino, Arthur, et al.
Publicado: (2015)

A Case of Amphetamine and Methamphetamine Intoxication in Cat
por: Chłopaś-Konowałek, Agnieszka, et al.
Publicado: (2022)

The Role of Cannabis Use in Suicidal Ideation Among Patients With Opioid Use Disorder
por: Naji, Leen, et al.
Publicado: (2021)

Cocaine- and Amphetamine-Regulated Transcript (CART) Peptide Plays Critical Role in Psychostimulant-Induced Depression
por: Meng, Qing, et al.
Publicado: (2018)

Investigating and addressing the immediate and long-term consequences of the COVID-19 pandemic on patients with substance use disorders: a scoping review and evidence map protocol
por: Naji, Leen, et al.
Publicado: (2021)

Dynamic immune and exosome transcriptomic responses in patients undergoing psychostimulant methamphetamine withdrawal
por: Wu, Hongjin, et al.
Publicado: (2022)

Corrigendum to ‘A comparison of electronically-delivered and face to face cognitive behavioural therapies in depressive disorders: A systematic review and meta-analysis’ [EClinicalMedicine 24 (2020) 100442]
por: Sanger, Nitika, et al.
Publicado: (2021)

Pitolisant, a wake‐promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol
por: Krief, Stéphane, et al.
Publicado: (2021)

Social functioning outcomes in men and women receiving medication-assisted treatment for opioid use disorder
por: van Reekum, Emma A., et al.
Publicado: (2020)

Cannabis use in patients treated for opioid use disorder pre- and post-recreational cannabis legalization in Canada
por: Rosic, Tea, et al.
Publicado: (2021)

Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review
por: Siefried, Krista J., et al.
Publicado: (2020)

Evaluating the evidence for macrophage presence in skeletal muscle and its relation to insulin resistance in obese mice and humans: a systematic review protocol
por: Bhatt, Meha, et al.
Publicado: (2017)

Gomafu lncRNA knockout mice exhibit mild hyperactivity with enhanced responsiveness to the psychostimulant methamphetamine
por: Ip, Joanna Y., et al.
Publicado: (2016)

Profile of suicide attempts and risk factors among psychiatric patients: A case-control study
por: Bhatt, Meha, et al.
Publicado: (2018)

Treatment outcomes in patients with opioid use disorder initiated by prescription: a systematic review protocol
por: Sanger, Nitika, et al.
Publicado: (2018)

Patient-Reported Goals of Youths in Canada Receiving Medication-Assisted Treatment for Opioid Use Disorder
por: Chai, Darren, et al.
Publicado: (2021)

Factors associated with opioid overdose during medication-assisted treatment: How can we identify individuals at risk?
por: Au, Vivian Y. O., et al.
Publicado: (2021)

Feasibility of behavioral activation group therapy in reducing depressive symptoms and improving quality of life in patients with depression: the BRAVE pilot trial
por: D’Elia, Alessia, et al.
Publicado: (2020)

The association between cannabis use and outcome in pharmacological treatment for opioid use disorder
por: Rosic, Tea, et al.
Publicado: (2021)

Cannabis use and opioid relapse: An exploratory survival analysis of prospectively collected data
por: Naji, Leen, et al.
Publicado: (2022)

Evaluation of clinical and inflammatory profile in opioid addiction patients with comorbid pain: results from a multicenter investigation
por: Dennis, Brittany B, et al.
Publicado: (2014)

Impact of ABCB1 and CYP2B6 Genetic Polymorphisms on Methadone Metabolism, Dose and Treatment Response in Patients with Opioid Addiction: A Systematic Review and Meta-Analysis
por: Dennis, Brittany B., et al.
Publicado: (2014)

The Effects of Amphetamine and Methamphetamine on the Release of Norepinephrine, Dopamine and Acetylcholine From the Brainstem Reticular Formation
por: Ferrucci, Michela, et al.
Publicado: (2019)

Increasing rates of methamphetamine/amphetamine-involved overdose hospitalizations in Washington State, 2010–2017
por: Njuguna, Henry, et al.
Publicado: (2021)

The Effectiveness of Topiramate in the Treatment of Amphetamine and Methamphetamine Use Disorder: A Randomized Controlled Trial
por: Moghaddam Sadegh, Amirali, et al.
Publicado: (2023)

Are patients’ goals in treatment associated with expected treatment outcomes? Findings from a mixed-methods study on outpatient pharmacological treatment for opioid use disorder
por: Rosic, Tea, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v4q7qqq2sd2pvdpu4ivflqfsl6